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Activation of SRF-Regulated Chromosomal
Templates by Rho-Family GTPases Requires
a Signal that Also Induces H4 Hyperacetylation
GTPases act independently of RhoA, but their relevance
to the response to extracellular signals has yet to be
demonstrated (Hill et al., 1995).
Several observations suggest that in addition to the
signal-induced potentiation of transcription factor activ-
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London WC2A 3PX ity, immediate-early gene transcription may require
modification of chromatin components. First, growthUnited Kingdom
factors and stress stimuli induce reversible histone H3
and HMG14 phosphorylation with kinetics similar to
those of c-fos transcription (Mahadevan et al., 1991;Summary
Edwards and Mahadevan, 1992; Barratt et al., 1994a,
1994b). Second, regulation by several inducible pro-Constitutively active forms of the small GTPases RhoA
(RhoA.V14) and Cdc42 (Cdc42.V12) induce expression moter elements, including the SRE, is inhibited by micro-
injection of antibodies against the coactivator proteinsof extrachromosomal SRF reporter genes in microin-
jection experiments, but only Cdc42.V12 can efficiently p300 and CBP (Arias et al., 1994), and the TCFs SAP-1
and Elk-1 are among the many transcription factorsactivate a chromosomal template. Both SAPK/JNK-
dependent or -independent signals can cooperate whose activity can be stimulated by CBP in transfection
assays (Janknecht and Nordheim, 1996a, 1996b). Al-with RhoA.V14 to activate chromosomal SRF report-
ers, and it is SAPK/JNK activation by Cdc42.V12 that though the molecular basis of these effects remains to
be determined, both CBP and p300 are acetyltransfer-allows it to activate chromosomal templates. Cooper-
ating signals can be bypassed by deacetylase inhibi- ases (Bannister and Kouzarides, 1996; Ogryzko et al.,
1996), and c-fos nucleosomes become hyperacetylatedtors. Three findings show that histone H4 hyperacety-
lation is one target for cooperating signals, although when transcription is activated (Allegra et al., 1987; Chen
and Allfrey, 1987). The functional significance of theseit alone is not sufficient: (1) Cdc42.V12, but not RhoA.V14,
induces H4 hyperacetylation; (2) cooperating signals phenomena has remained unclear.
In this study, we set out to test whether activation ofuse the same SAPK/JNK-dependent or -independent
pathways to induce H4 hyperacetylation; (3) growth Rho-controlled signal pathways is sufficient for activa-
tion of the chromosomal c-fos gene, as is the case withfactor and stress stimuli induce substantial H4 hypera-
cetylation, detectable in reporter gene chromatin. Ras (Stacey et al., 1987). We used a microinjection ap-
proach as a short-term cell-based assay to minimizeThese data establish a link between signal-regulated
acetylation events and gene transcription. autocrine effects that may complicate the interpretation
of transfection assays (see Cowley et al., 1994; Minden
et al., 1994). We show that although the activated form
Introduction of RhoA can activate microinjected templates, it is un-
able to activate either the chromosomal c-fos gene or
The serum response element (SRE) is a growth factor- integrated SRF-controlled reporter genes unless addi-
regulated promoter element that is essential for the acti- tional signaling pathways areactivated. The cooperating
vation of immediate-early genes, such as c-fos and signals may be either SAPK/JNK-dependent or -inde-
Egr-1, by extracellular signals. The c-fos SRE, which pendent and can be substituted by treatment of cells
binds a transcription factor complex comprising SRF with deacetylase inhibitors. Finally, we show that one
(serum response factor; Norman et al., 1988) and a mem- target of the cooperating signals is the hyperacetylation
ber of the TCF family (ternary complex factor; Shaw of histone H4, which is also induced in reporter gene
et al., 1989), is a convergence point for several signal chromatin following growth factor stimulation. Our data
transduction pathways. TCF activity is regulated via provide evidence that acetylation events, including
phosphorylation of their C-terminal transcriptional acti- chromatin modifications, can be a prerequisite for acti-
vation domains by MAP kinases (for review and refer- vation of immediate-early gene expression.
ences, see Treisman, 1994; Price et al., 1996; Raingeaud
et al., 1996). In contrast, SRF activity is regulated by a
novel signal pathway that involves the Rho-family GTPase
ResultsRhoA. This pathway, which acts independently of known
MAPK pathways, is regulated by agents such as serum
Differential Activation of Chromosomalor LPA acting via heterotrimeric G protein±coupled re-
and Extrachromosomal c-fos Genesceptors (Hill et al., 1995; J. Wynne and R. T., unpublished
by Rho-Family GTPasesdata). SRF activity can also be potentiated by intracellu-
We used a microinjection assay to test whether ex-lar expression of activated forms of both RhoA and two
pression of the chromosomal c-fos gene can be in-other Rho-family proteins, Cdc42 and Rac1; the latter
duced by activated forms of RhoA (RhoA.V14), Cdc42
(Cdc42.V12), or Rac1 (Rac1.V12). Purified recombinant*To whom correspondence should be addressed.
proteins, normalized for GTP binding activity, were in-²Present address: UCSF Cancer Center, Box 0128, San Francisco,
California 94143-0128. jected into the cytoplasm of serum-deprived NIH3T3
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Figure 1. Differential Activation of Chromosomal and Extrachromosomal c-fos Genes by Rho-Family Proteins
(A) Cdc42.V12 and Rac1.V12, but not RhoA.V14, activate the chromosomal c-fos gene. RhoA.V14, Cdc42.V12, or Rac1.V12 proteins, together
with marker guinea pig IgG, were injected into the cytoplasm of serum-deprived NIH3T3 cells. Two hours later, cells were fixed and Fos and
marker proteins detected by indirect immunofluorescence.
(B) RhoA.V14 can activate a coinjected c-fos gene derivative. RhoA.V14, Cdc42.V12, and Rac1.V12 proteins were injected into the nuclei and
cytoplasm of serum-deprived NIH3T3 cells together with a plasmid containing a 9E10-epitope-tagged human c-fos gene (pF711±9E10). Two
hours later, cells were fixed and Fos.9E10 and marker proteins detected by indirect immunofluorescence.
cells together with a marker protein, and c-fos expres- RhoA-Dependent Signals Are Necessary
but Not Sufficient for Activationsion was assayed by indirect immunofluorescence 2 hr
later. Surprisingly, Cdc42.V12 and Rac1.V12 induced of a Chromosomal SRE
Differential activation of chromosomal and injectedc-fos expression but RhoA.V14 did not, although all
proteins could induce appropriate cytoskeletal rear- c-fos templates by Rho-family proteins might reflect a
property of either the SRE itself or its interaction withrangements (Figure 1A and data not shown).The rapidity
of the response, and the lack of gene induction in neigh- other c-fos promoter elements. To address this issue,
we constructed cell lines carrying chromosomal SRF-boring uninjected cells, suggests that it is not mediated
by autocrine pathways. Similar results were obtained controlled reporter genes. One reporter line, SRE-lacZ,
carries the bacterial lacZ gene controlled by a promoterfollowing nuclear injection of Rho-family expression
plasmids (data not shown). In contrast, all the GTPases comprising the RSV TATA box and three SRF binding
sites; a second reporter cell line, SRE-FosHA, containscould induce expression of an epitope-tagged c-fos
gene (Fos-9E10) coinjected into the nuclei of NIH3T3 an epitope-tagged derivative of our previously charac-
terized reporter gene 3D.AFos (Hill et al., 1995). Bothcells (Figure 1B; data not shown). Similar results were
obtained when Fos-9E10 was coinjected with Rho-fam- SRE-lacZ and SRE-FosHA genes lack binding sites for
TCF and respond toserum and LPA; they do not respondily expression plasmids (data not shown). Thus, the abil-
ity of RhoA.V14 to activate c-fos gene expression differs to stress stimuli such as UV irradiation or subinhibitory
anisomycin concentrations, although a subset of theaccording to the context of the DNA template.
Activation of Chromosomal Templates by SRF
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Figure 2. RhoA Signaling Is Necessary but Not Sufficient for Activation of the Chromosomal SRF-Controlled Templates
(A) Cdc42.V12 activates a chromosomal SRE while RhoA.V14 does not. RhoA.V14 and Cdc42.V12 proteins were injected into the cytoplasm
of serum-deprived SRE-lacZ cells. Two hours after injection, cells were fixed and stained for marker and lacZ reporter activity. Refractive
lines are from scores on the coverslip.
(B) An extrachromosomal SRE-FosHA template is equally responsive to Cdc42.V12 and RhoA.V14 proteins. Recombinant GTPases were
injected into the nuclei and cytoplasm of SRE-FosHA cells together with various concentatrations of the SRE-Fos9E10 reporter plasmid. Cells
were fixed 2 hr later, and marker proteins and the products of the injected and chromosomal reporter genes were detected by immunofluores-
cence with 9E10 and Y11 antibodies, respectively. Values represent mean 6 SE of three independent experiments, 50±100 cells per treatment.
(C) RhoA but not Cdc42 mediates induction of the chromosomal SRF-controlled reporter. Left panel, ADP ribosylation±resistant RhoA (RhoA.I41)
can mediate serum-induced signaling to C3 transferase±injected cells. C3 transferase and marker protein were injected into the cytoplasm
of SRE-lacZ cells either alone or with wild-type RhoA or RhoA-I41 (both at 3 mg/ml) as indicated. Thirty minutes after injection, cells were
stimulated with 10% FCS, and after another 2 hr fixed and stained for marker and lacZ activity. Representative fields of injected cells are
shown; lines are scores on the coverslip. Right panel, summary of two experiments; PAK.N, injection of the Cdc42/Rac1-binding domain of
PAK (mean 6 half range; 100±200 cells injected for each treatment).
cells are induced by TPA treatment (data not shown). As Cdc42.V12 could activate coinjected SRE-lacZ and
SRE-FosHA templates (Figure 2B). Since the two cellwith the chromosomal c-fos gene, neither chromosomal
reporter gene was activated upon microinjection of lines are independently derived transformants con-
taining different basal promoter and reporter gene se-RhoA.V14, although both were activated by Cdc42.V12
(Figures 2A and 2B). In contrast, both RhoA.V14 and quences, their identical behavior, both in these assays
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and those presented below, must reflect properties of of these pathways by stress stimuli such as UV irradia-
SRF itself. tion or subinhibitory anisomycin concentrations would
We next considered the possibility that the differential allow activated RhoA to induce chromosomal reporter
response of the reporter genes to Rho-family proteins gene expression. SRE-lacZ cells were injected with re-
might arise because the SRF-controlled reporter genes combinant RhoA.V14, immediately stimulated with ani-
are more sensitive to Cdc42.V12 than RhoA.V14, and a somycin or UV irradiation, and reporter gene activity
saturating amount of template is used in the coinjection assayed 2 hr later. Although neither anisomycin nor UV
experiments. We therefore performed a template titra- irradiation alone activated the chromosomal SRE-lacZ
tion experiment (Figure 2B). SRE-FosHA cells were in- reporter gene, both these stimuli activated the reporter
jected with RhoA.V14 or Cdc42.V12, together with de- in the presence of RhoA.V14; in contrast, TPA treatment,
creasing amounts of an SRE-Fos9E10 reporter gene which does not regulate stress-activated MAPKs in
(identical to the SRE-FosHA but with the 9E10 epitope; these cells, did not cooperate with activated RhoA to
see Experimental Procedures), and expression of both activate the reporter (Figure 3A). When SRE-lacZ cells
the injected and chromosomal genes monitoredsimulta- were preinjected with expression plasmids producing
neously. Both RhoA.V14 and Cdc42.V12 activated the either MEKK or v-src, both of which can activate the
coinjected reporter template in a concentration-depen- SAPK/JNK pathway (Devary et al., 1992; Yan et al.,
dent manner, with half-maximal response occurring at 1994), subsequent injection of RhoA.V14 protein acti-
about 100 ng/ml injected reporter DNA (about 2±20 cop-
vated reporter expression (Figure 3B).
ies; see Experimental Procedures). Similarly, when the
We used specific inhibitors of different MAPK path-
concentrations of recombinant GTPases were titrated
ways to further investigate their involvement in the acti-
over a 20-fold range, reporter gene expression dimin-
vation of the chromosomal SRF-controlled reporters. To
ished in parallel (data not shown). Thus, the differential
inhibit the SAPK/JNK pathway, we injected either recom-response of the chromosomal SRE to the activated Rho-
binant JNK.KA, a kinase-inactive mutant of p54SAPKb,family GTPases must reflect difference in their signaling
or an expression plasmid encoding SEK-AL, a nonacti-properties rather than merely signal strength.
vatable SEK mutant (Yan et al., 1994). Both proteinsWe previously showed that RhoA function is required
inhibited activation of chromosomal SRF-controlled re-for the response of a transfected SRF-controlled re-
porter genes by either Cdc42.V12 or the combination ofporter gene toserum or LPA stimulation (Hill et al., 1995).
RhoA.V14 and anisomycin (Figure 3C); in control experi-To confirm that functional RhoA is indeed necessary for
ments, both JNK.KA and SEK-AL prevented Cdc42.V12-induction of a chromosomal SRE by external stimuli,
and stress-induced phosphorylation of a coexpressedSRE-lacZ cells were injected with the enzyme C3 trans-
SAPK/JNK substrate, the Jun N terminus (data notferase, which ADP-ribosylates and specifically inactivates
shown; A. S. A. and R. T., submitted). In contrast, treat-RhoA. This treatment abolished serum- and LPA-induced
ment of the cells with the small-molecule inhibitorsSRE-lacZ reporter expression (Figure 2C); similar results
PD98059 and SB203580, which inhibit the ERK and p38were obtained when RhoA was inactivated by injection
MAPK pathways, respectively (Alessi et al., 1995; Cuendaof the RhoA-binding domain of the RhoA effector kinase
PKN (data not shown). Serum induction of the reporter et al., 1995), had no effect on the ability of anisomycin
gene was restored when cells were coinjected with to cooperate with RhoA.V14 (Figure 3C, left panel). We
both C3 transferase and the C3-resistant RhoA mutant also tested whether Cdc42 or Rac1 activity is required
RhoA.I41 (Figure 2C). In contrast, serum- or LPA- for SRF activation by RhoA.V14/anisomycin by coinjec-
induced reporter gene expression expression was unaf- tion of recombinant PAK.N, theN-terminal GTPase-bind-
fected by expression of PAK.N, the GTPase-binding do- ing domain of the Cdc42/Rac1 effector PAK (Manser et
main of the Cdc42/Rac1 effector kinase PAK (Manser al., 1994). PAK.N had no effect on activation of the chro-
et al., 1994), which specifically inhibits signaling by mosomal reporter in this assay, although, as expected,
Cdc42 and Rac1 (Figure 2C; see below). Taken together it effectively blocked activation by Cdc42.V12 (Figure
with the inability of the constitutively active RhoA.V14 3C, left panel). Conversely, titration of cellular RhoA by
to activate the chromosomal reporter genes, these data PKN.N, the RhoA-binding domain of its effector PKN,
show that RhoA is necessary, but not sufficient, for acti- did not block activation of the reporter by Cdc42.V12,
vation of the chromosomal SRE in response to serum
although it effectively blocked activation by RhoA.V14/
and LPA stimulation.
anisomycin (Figure 3C, left panel).
The above results show that activation of the SAPK/The SAPK/JNK Pathway Cooperates with
JNK pathway is required for activation of the chromo-RhoA.V14 and Is Necessary for Induction
somal SRF-controlled reporter gene by Cdc42.V12 orof the Chromosomal SRE by Cdc42.V12
RhoA.V14/anisomycin. To confirm that SAPK/JNK activ-One interpretation of the observations described in the
ity is specifically required for only activation of chromo-preceding sections is that Cdc42.V12, butnot RhoA.V14,
somal templates, we repeated the experiments using acan activate a signaling pathway that is specifically re-
coinjected SRE-Fos9E10 reporter gene, which is effi-quired for the activation of chromosomal templates. We
ciently activated by both Cdc42.V12 and RhoA.V14:therefore sought to identify such signaling pathways.
JNK.KA blocked activation by neither GTPase (compareIntriguingly, previous studies have demonstrated that
Figures 3C and 3D). SAPK/JNK activation thus repre-the activated forms of Cdc42 and Rac1, but not RhoA,
sents an additional signal specifically required for acti-can potentiate activity of stress-activated MAPK path-
vation of chromosomal SRF reportergenes by RhoA.V14ways in transfection experiments (Coso et al., 1995; Min-
den et al., 1995). We therefore tested whether activation and Cdc42.V12.
Activation of Chromosomal Templates by SRF
479
Figure 3. RhoA.V14 Can Cooperate with Stress Stimuli to Activate a Chromosomal SRE; Both This and Activation by Cdc42.V12 Require
SAPK/JNK Activity
(A) Stress stimuli cooperate with RhoA.V14. RhoA.V14 protein was injected into the cytoplasm of serum-deprived SRE-lacZ cells, which were
stimulated 20 min later as indicated and processed for marker and lacZ activity after a further 2 hr. Representative fields are shown. Bars
represent the percentage of injected cells staining positive for lacZ from three independent experiments (mean 6 SD, 50±100 cells injected
for each inducing agent).
(B) MEKK1 and v-src cooperate with RhoA.V14. Expression plasmids encoding MEKK1 or v-src were injected into the nuclei of SRE-lacZ
cells, together with marker 1 (rabbit Ig). After 2 hr, cells received a second, cytoplasmic injection of marker 2 (guinea pig Ig), with or without
RhoA.V14 protein. After a further 2 hr, the cells were fixed and assayed for markers and lacZ activity. Bars represent the percentage lacZ-
positive cells in two independent experiments (mean 6 half range, 50±100 cells injected per experiment).
(C) Chromosomal SRE activation by anisomycin/RhoA.V14 and Cdc42.V12 involves the SAPK/JNK pathway. Left panel: RhoA.V14 or Cdc42.V12
and marker proteins were injected into the cytoplasm of serum-deprived SRE-lacZ cells either alone, together with PAK.N, PKN.N, or kinase-
inactive p54SAPKb (JNK.KA), or treated with 50 mM PD98059 or 10 mM SB203580 as indicated. RhoA.V14-injected cells were immediately
treated with anisomycin. Two hours later, cells were fixed and assayed for marker and lacZ activity. Bars represent the percentage of lacZ-
positive injected cells in three independent experiments (mean 6 SE, 50±100 cells injected for each condition) except for PD98059 and
SB203580 (mean 6 half range of two experiments). Right panel: expression plasmids encoding RhoA.V14 or Cdc42.V12 together with kinase-
inactive SEK (SEK-AL) were injected into the nuclei of serum-deprived SRE-FosHA cells as indicated; RhoA.V14-injected cells were immediately
treated with anisomycin. Two hours later, cells were fixed and assayed for marker and FosHA expression. Bars represent the percentage of
FosHA-positive injected cells in three independent experiments (mean 6 SE, 50±100 cells injected for each experiment).
(D) SAPK/JNK activity is not required for activation of an extrachromosomal SRE. The SRE-Fos9E10 reporter gene was injected into the nuclei
of SRE-lacZ cells, together with proteins as in (C) (left) and treated identically. Bars represent the percentage of 9E10-positive injected cells
in three independent experiments (mean 6 SE, 50±100 cells injected for each condition) except for PD98059 and SB203580 (mean 6 half
range of two experiments).
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Other Signal Pathways Can Cooperate
with Activated RhoA
To test whether the SAPK/JNK pathway is necessary
for mitogen-induced activation of a chromosomal SRE,
we examined whether microinjection of JNK.KA could
inhibit the ability of SRE-FosHA cells to respond to
serum or LPA stimulation. Inhibition of the SAPK/JNK
pathway by injection of JNK.KA substantially inhibited
the response to LPA stimulation but had no effect upon
the ability of the reporter gene to respond to serum,
suggesting that serum can induce a signal(s), distinct
from SAPK/JNKs, which can also cooperate with RhoA
(Figure 4A). We therefore examined other signal path-
ways associated with mitogen and stress stimuli.
SRE-FosHA cells were injected with expression plas-
mids encoding RhoA.V14 and other signaling molecules
or their derivatives. In agreement with previous results,
Ras.R12, an activated Ras protein, could not activate
the SRF-controlled reporter genes although it efficiently
activated c-fos transcription (Stacey et al., 1987; Hill et
al., 1995; data not shown). However, Ras.R12 cooper-
ated effectively with RhoA.V14, even though specific
activation of the ERK pathway by expression of either
activated Raf (Raf-CAAX; Leevers et al., 1994), activated
MEK (MEK-EE; Cowley et al., 1994), or TPA, could not
(Figure 4B). The ability of activated Ras.R12 to cooper-
ate with RhoA.V14 was prevented by expression of SEK-
AL, suggesting that Ras.R12 cooperation is mediated
by the SAPK/JNK pathway (Figure 4B); consistent with
this, Ras.R12 injection promoted phosphorylation of the
Jun N terminus in control experiments (data not shown).
Finally, we tested whether RhoA.V14 could cooperate Figure 4. Other Pathways Can Cooperate with Activated RhoA
with an activated mutant of another stress-activated (A) The SAPK/JNK pathway is necessary for chromosomal SRE
kinase, MKK3 (MKK3E; Raingeaud et al., 1996). Injection activation by LPA but not by serum. Kinase-inactive p54SAPKb
(JNK.KA) and marker proteins were injected into the cytoplasm ofof RhoA.V14 and MKK3E expression plasmids efficiently
SRE-FosHA cells, which were stimulated 20 min later as indicated.induced SRE-FosHA expression, which was insensitive
Cells were then fixed and assayed for expression of FosHA andto blockade of the SAPK/JNK pathway by both JNK.KA
marker. Bars show percentage of FosHA-positive injected cells from
and SEK-AL (Figure 4B). Thus, in addition to the SAPK/ two representative experiments (mean 6 half range, 50±100 cells
JNK pathway, at least one other signal pathway can per treatment).
cooperate with RhoA.V14 to activate a chromosomal (B) RhoA can cooperate with MKK3E and Ras but not the ERK
pathway. Expression plasmids were injected into the nuclei of se-SRE (see Discussion).
rum-deprived SRE-FosHA cells, together with kinase-inactive
p54SAPKb protein (JNK.KA), as indicated. Four hours later, the cells
were fixed and analyzed for marker and FosHA expression. BarsDeacetylase Inhibitors Cooperate
represent the percentage of 9E10-positive injected cells in threewith RhoA.V14
independent experiments (mean 6 SE, 50±100 cells injected for each
One potential explanation for the differential signal re- condition) except for Raf-RhoA.V14/RasR12/SEK-AL and RafCAAX
quirements of extrachromosomal and integrated reporter (mean 6 half range of two experiments).
genes is that signals that cooperate with RhoA.V14, but
not RhoA.V14 itself, can induce a chromatin or transcrip-
tion factor modification necessary only for transcription inhibitors was not sensitive to blockade of the SAPK/
JNK pathway by expression of SEK-AL, demonstratingof a chromosomal template. Recent findings have impli-
cated acetylation of both chromatin components and that the inhibitors do not act via this pathway (Figure
5A). Similar results were obtained in SRE-FosHA cellsthe transcriptional machinery in regulation of gene ex-
pression, so we tested whether deacetylase inhibitors (data not shown). We also investigated whether deacety-
lase inhibitors can cooperate with activated RhoA to(Yoshida et al., 1995) can cooperate with RhoA.V14 to
induce chromosomal reporter gene expression. induce expression of chromosomal immediate-early
genes. Treatment of NIH3T3 cells with either butyrateSRE-lacZ cells were injected with an expression plas-
mid encoding RhoA.V14 and stimulated with deacety- or TSA alone was not sufficient to induce expression
of either c-fos or Egr-1, another SRE-controlled gene;lase inhibitors, and activity of the reporter gene was
assessed. Both sodium butyrate and the specific deace- however, both inhibitors cooperated with activated
RhoA.V14to induce chromosomal c-fos or Egr-1expres-tylase inhibitor trichostatin A (TSA) could cooperate with
RhoA.V14 to induce the chromosomal SRE in SRE-lacZ sion (Figure 5B). These data suggest that activation of
RhoA.V14-induced signaling pathways together with ancells. Cooperation between RhoA.V14 and deacetylase
Activation of Chromosomal Templates by SRF
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Figure 5. Deacetylase Inhibitors Cooperate
with RhoA.V14 to Activate Chromosomal
SRF-Controlled Gene Expression
(A) Deacetylase inhibitors do not act via the
SAPK/JNK pathway. Expression plasmids
encoding RhoA.V14 and kinase-inactive SEK
(SEK-AL) were injected into the nuclei of SRE-
lacZ cells as indicated. After 2 hr, the cells
were treated with sodium butyrate (1 mM),
trichostatin A (10 nM), or anisomycin, and
after a further 2 hr fixed and assayed for lacZ
activity and marker protein. Bars represent
the percentage of lacZ-positive injected cells
in three independent experiments (mean 6
SE, 50±100 cells injected for each condition)
except for TSA (mean 6 half range, two ex-
periments).
(B) Trichostatin A cooperates with RhoA.V14
to activate chromosomal c-fos (top panels) and
Egr-1 (lower panels). Recombinant RhoA.V14
and kinase-inactive p54SAPKb (JNK.KA)
were injected into serum-deprived NIH3T3
cells as indicated, together with marker pro-
tein. After 2 hr, the cells were stimulated with
TSA and stained for Fos, Egr-1, and marker
proteins 2 hr later.
acetylation event is sufficient for induction of both chro- include both stimuli that are sufficient to activate a chro-
mosomal SRF-controlled reporter, such as serum ormosomal SRF-controlled reporter and immediate-early
gene expression. LPA, and stimuli that can cooperate with RhoA.V14 to
do so, such as anisomycin and UV irradiation. However,
TPA, which does not cooperate with RhoA.V14, alsoExtracellular Stimuli Induce Rapid Histone H4
Acetylation in Reporter Gene Chromatin induced H4 acetylation (Figure 6A; see Discussion). Sim-
ilar changes were detected using the anti-acetyllysineThe observed cooperation between RhoA.V14 and de-
acetylase inhibitors led us to search for proteins whose antibody (data not shown). In contrast, little change in
H3 acetylation was detectable with either anti-acetylacetylation status changes in response to extracellular
signals. We therefore examined the effects of extracellu- H3 or anti-acetyllysine antibodies (Figure 6A; data not
shown). Hyperacetylation of H4 was detectable within 15lar stimuli on histone acetylation status. Histones were
partially purified from growing, serum-starved, or stimu- min of stimulation and continued to increase for several
hours; a substantial proportion of total H4 became acet-lated SRE-FosHA cells and fractionated on acid-urea
gels to resolve different acetylated histone isoforms, ylated, as revealed by examination of the histone prepa-
rations by direct staining of the gels (Figure 6B; seewhich were detected by immunoblotting with antibodies
raised against either acetylated tetrahymena histones Discussion).
We next investigated whether extracellular signals in-H4 or H3 (Lin et al., 1989) or anti-acetyllysine (Hebbes
et al., 1989). The tetrahymena H4 antibody cross-reacts creased the density of H4 hyperacetylation at the SRF-
controlled reporter and c-fos genes by immunoprecipi-specifically with acetylated mammalian H4, reacting
preferentially with tetraacetylated H4, and to a lesser tation of cross-linked chromatin (Braunstein et al., 1993).
Serum-deprived or stimulated cells were cross-linkedextent with triacetylated H4, but retaining only low reac-
tivity for the diacetylated form (Meistrich et al., 1992; using formaldehyde, and a crude nuclear lysate soni-
cated to generate DNA fragments 200±1000 base pairsPerry et al., 1993); the anti-acetyllysine antibody R47
also preferentially reacts with hyperacetylated histone in length. Following immunoprecipitation and reversal
of cross-links, immunoprecipitated DNA was recoveredisoforms (Hebbes et al., 1989, 1994). Serum-starved
cells exhibited substantially reduced acetylation of H4 and the presence of reporter gene sequences ascer-
tained using the PCR. In this assay, immunoprecipitationcompared with cycling cells (Figure 6A). In addition to
the deacetylase inhibitors, several extracellular stimuli is specific, since it is not observed with nonspecific IgG,
and is dependent on prior cross-linking (Figure 6B andcaused a rapid increase in hyperacetylation of H4. These
Cell
482
Figure 6. Extracellular Stimuli Induce His-
tone H4 Acetylation
(A) Extracellular signals cause histone hyper-
acetylation. SRE-FosHA cells were main-
tained in 0.5% FCS for 36 hr and stimulated
for various times as indicated. Histones were
extracted, fractionated on acid-urea gels,
transferred to Immobilon membrane, and de-
tected anti-acetyl H4 serum (left panel) or
anti-acetyl H3 serum (right panel) (Lin et al.,
1989). Similar results were obtained using
anti-acetyllysine serum R47 (Hebbes et al.,
1989; data not shown).
(B) Time course of H4 acetylation. Cells were
stimulated as indicated for the times shown
(minutes; hours indicated by open type). Top,
acetylated histone H4 visualized by immu-
noblot. Bottom, duplicate gel run in parallel
stained with Coomassie blue, acetylated H4
isoforms indicated by white circles (tetraace-
tylated H4 comigrates with an unidentified
protein). Note that, as observed previously,
approximately 50% of the H4 in resting cells
is monoacetylated (see Hebbes et al., 1989,
1994).
(C) Extracellular signals induceH4 hyperacet-
ylation at the SRF-controlled reporter gene
chromatin. Lanes 1±5: cells were stimulated
as indicated, cross-linked with HCHO, and
nuclear lysates prepared. After precipitation
with the indicated antibodies, reporter gene
DNA was detected by PCR. Lanes 6 and 7:
PCR controls with water (lane 6) or 50 ng
genomic DNA from each cell line (lane 7).
data not shown). Moreover, under the conditions used relationship between the signaling pathways involved
in histone hyperacetylation and those that cooperatefor immunoprecipitation, treatment of starved cells with
sodium butyrate substantially increases the yield of im- with activated RhoA to induce expression of chromo-
somal target genes. To do this, we developed an immu-munoprecipitated reportergene DNA, indicating that the
density of hyperacetylated H4 is increased by this treat- nofluorescence assay for H4 hyperacetylation. Titration
experiments with both the anti-acetyllysine and anti-ment (Figure 6B, compare lanes 1 and 5). Hyperacetyla-
tion of H4 in reporter gene chromatin was induced by acetyl H4 antibodies established staining conditions un-
der which acetylated histone H4 immunoreactivity wasall stimuli that induced hyperacetylation of bulk H4 as
assessed by immunoblot, including serum, anisomycin, virtually undetectable in serum-deprived cells but re-
mained readily detectable in cells treated with a varietyand TPA, although induction by anisomycin was rela-
tively weak (Figure 6B, lanes 1±4). Thus, extracellular of stimuli, in agreement with the immunoblotting data
(Figure 7A). Consistent with the relatively large amountsignals cause rapid hyperacetylation of histone H4 in
reporter gene chromatin. of hyperacetylated H4 seen by direct staining of gels,
staining was uniform: discrete foci were undetectable
even upon examination by confocal fluorescence mi-Stimuli that Cooperate with RhoA for SRE Activation
croscopy (Figure 7A and data not shown; see Discus-Utilize the Same Signal Pathways to Induce
sion). Stimulus-induced H4 hyperacetylation was notH4 Hyperacetylation
affected following treatment with concentrations of acti-The above data show that extracellular stimuli induce
nomycin D sufficient to inhibit transcription, indicatingrapid changes in the acetylation status of histone H4 at
our reporter genes. We next wished to investigate the that it occurs independently of ongoing transcription
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Figure 7. Cooperating Signals, but Not
RhoA.V14, Induce H4 Hyperacetylation
(A) Immunofluorescence assay for histone
hyperacetylation. Serum-deprived SRE-FosHA
cells were either left alone or stimulated with
TSA, serum, orserum with 5 mg/ml actinomy-
cin D. After 1 hr, cells were fixed and histone
acetylation detected by immunofluorescence
using anti-acetyl H4 serum at high dilution.
Similar results were obtained with anti-acetyl
lysine serum (data not shown).
(B) Expression plasmids encoding RhoA.V14,
Cdc42.V12, or MKK3E were injected into the
nuclei of SRE-FosHA cells together with ki-
nase-inactive p54SAPKb (JNK.KA), as indi-
cated, and marker protein; where indicated,
cells were treated 20 min later with aniso-
mycin or TPA. Two hours later, cells were
fixed and stained for acetylated histone
using anti-acetyl H4 serum at high dilution.
(C) Detection of hyperacetylated H4 by R47
anti-acetyllysine serum. Bars indicate the
percentage of R47-positive injected cell
(mean 6 SE of three experiments, 50±100
cells injected for each condition, except for
MKK3E, mean 6 half range of two experi-
ments).
(Figure 7A). In contrast, upon titration of the anti-acetyl H4 hyperacetylation. Most importantly, stimuli that coop-
erate with activated RhoA, the same SAPK/JNK-depen-H3 antibody, immunofluoresence signals in both serum-
deprived and stimulated cells decreased in parallel, con- dent or -independent signaling pathways, are required
for bothH4 hyperacetylationand the transcriptional acti-sistent with the immunoblotting data (data not shown).
We used the immunofluorescence assay to examine vation of a chromosomal reporter gene. These results
therefore establish H4 hyperacetylation as a target forthe abilities of Rho-family and other signaling molecules
to induce H4 hyperacetylation in microinjected cells. the cooperating signal pathways.
Microinjection of RhoA.V14 did not induce H4 hypera-
cetylation (Figure 7B, panel 1). In contrast, H4 hypera- Discussion
cetylation was induced by Cdc42.V12, two stimuli that
cooperate with RhoA.V14to activate chromosomalSRF- Two Distinct Signals Are Required for
controlled reporter gene, anisomycin, and MKK3E (Figure Activation of a Chromosomal SRE
7B, panels 2±4), and also upon activation of the ERK Our data show that activation of a chromosomally lo-
pathway by TPA, which does not (Figure 7B, panel 5). cated SRF-controlled reporter gene is dependent on
We next tested the dependence of induced H4 hyp- two kinds of signal, neither of which is by itself sufficient
eracetylation on the SAPK/JNK pathway. Induction of for activation (Figure 8). One signal, which is sufficient
H4 hyperacetylation by Cdc42.V12 and by anisomycin for activation of a transfected or microinjected template,
was effectively blocked by coinjection of JNK.KA (Fig- can be supplied either by growth factors or by activated
ure 7B, compare panels 2 and 6, 3 and 7); similar results forms of either RhoA, Cdc42, or Rac1, and is indepen-
were obtained with UV irradiation (data not shown). In dent of known MAPK pathways (Hill et al., 1995). The
contrast, histone H4 hyperacetylation brought about by second signal, which is necessary but not sufficient for
MKK3E and TPA was not blocked by coinjected JNK.KA efficient activation of chromosomal templates, is in-
(Figure 7A, panels 4 and 8; Figure 7C). These results duced by growth factors, stress stimuli, activated Cdc42,
and TNFa (unpublished data), butnot by activated RhoA.show that several stimuli, but not RhoA.V14, can induce
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into cellular DNA? In principle, this might arise from
differential nuclear location of the two types of template;
however, we favor the view that it reflects differences
in chromatin structure. The nucleoprotein structure
adopted by microinjected DNA has not been investi-
gated, but several studies of transfected genes have
shown that both their nucleoprotein structure and regu-
latory properties differ from those of chromosomal
genes. Transfected DNA is assembled into repeating
nucleosome-like structures (Innis and Scott, 1983; Cer-
eghini and Yaniv, 1984), which exhibit abnormal repeat
lengths and salt solubility (Jeong and Stein, 1994a,
1994b) and can be abnormally accessible to transcrip-
tion factors (Archer et al., 1992). Moreover, even thoughFigure 8. Signaling Pathways to Extrachromosomal and Chromo-
somal SRF Sites the nucleoprotein structure of transfected DNA can be
perturbed by deacetylase inhibitors (Innis and Scott,DNAs are shown schematically as lines, with the SRF binding site
an open box. The nucleosomal character of the chromosomal site 1983), transfected and integrated DNAs often respond
is indicated by closed circles; absence of these symbols from the differently to such treatments (Bresnick et al., 1990;
plasmid DNA does not imply the absence of nucleoprotein struc- Schlake et al., 1994; Pennie et al., 1995; Van Lint et al.,
tures on this template. Signaling pathways from Rho-family proteins
1996). Our results provide further evidence that transfec-to SRF are indicated by solid lines, and the ªchromosome-specificº
tion or microinjection assays may underestimate thesignaling pathways are shown as dashed lines. Acetylation of H4
contribution of the nucleoprotein environment to theand other components, indicated by question marks, is indicated
schematically by ªAc.º Regulation may proceed either through regu- requirements for transcriptional activation.
lation of acetyltransferases or deacetylases. For discussion, see
text.
Chromatin Modifications and Immediate-Early
Gene Expression
H4 hyperacetylation can be induced in quiescent cellsTreatment of cells with the deacetylase inhibitors so-
dium butyrate or trichostatin A bypasses the require- by a variety of extracellular stimuli, but not by activation
of RhoA-controlled signal pathways. Immunofluores-ment for the second signal.
What is the molecular target for the cooperating signal cence experiments revealed no evidence for the distinct
foci of hyperacetylated H4 that might be expected ifpathway? The ability of deacetylase inhibitors to substi-
tute for it strongly suggests that it controls an acetylation hyperacetylation were restricted to a relatively small
number of active genes; consistent with this, accumula-event specifically required for transcriptional activation
by SRF in a chromosomal context. Our data strongly tion of hyperacetylated isoforms of H4 was detectable
even by direct staining of thehistone gels. H4 hyperacet-suggest that the signal pathways used by cooperating
stimuli to induce transcription are the same as those ylation is detectable within 15 min of stimulation, but
hyperacetylated H4 continues to accumulate for severalused to induce hyperacetylationof histone H4. However,
it is clear that H4 hyperacetylation per se cannot be hours, by which time both reporter and c-fos transcrip-
tion has ceased. Signal-induced H4 hyperacetylationsufficient. Thus, stimuli that cooperate with activated
RhoA via the SAPK/JNK pathway, such as anisomycin can occur even when transcription is blocked by actino-
mycin D. Moreover, stimuli that are not sufficient forand TNFa, also induce H4 hyperacetylation via the
SAPK/JNK pathway, while activated MKK3 both cooper- transcriptional activation of the reporter genes can in-
duce H4 hyperacetylation. Taken together, these obser-ates with RhoA and induces H4 hyperacetylation inde-
pendently of the SAPK/JNKs. Moreover, Cdc42.V12 but vations suggest a model in which signal-induced H4
hyperacetylation represents a global response of thenot RhoA.V14 induces H4 hyperacetylation in an SAPK/
JNK-dependent manner, and it is the ability of Cdc42.V12 cell to stimulation, perhaps representing a prerequisite
for transcription rather than a modification that is tar-to activate the SAPK/JNK pathway that allows it to acti-
vate chromosomal templates. Nevertheless, H4 hypera- geted to specific genes concomitant with their activa-
tion. Given the substantial basal histone acetyltransfer-cetylation isalso induced following activation of the ERK
pathway, which does not cooperate with RhoA.V14. It ase activity in serum-starved NIH3T3 cells, regulated
changes in H4 acetylation status could be broughtis therefore likely that the cooperating signals induce an
additional acetylation event(s). Recent studies suggest about either directly, by regulation of acetyltransferase
or deacetylase activities themselves, or indirectly, bythat in addition to chromatin components, both basal
and sequence-specific transcription factors are sub- regulation of their access to substrate.
Recent studies have established direct links betweenstrates for acetylases (Gu and Roeder, 1997; Imhof et
al., 1997); however, it remains possible that cooperating the enzymes involved in histone acetylation and compo-
nents of the transcriptional apparatus. Histone acetyl-and noncooperating signals induce functionally distinct
patterns of H4 acetylation that cannot be distinguished transferase activity is associated with TAFII250 (Mizzen
et al., 1996) and coactivator complexes such as theby our antibodies.
Why should activated RhoA be sufficient for SRE and yeast Ada and SAGA complexes (Grant et al., 1997)
and the metazoan CBP/p300 complexes (Bannister andc-fos activation when templates are injected or trans-
fected but not when the same templates are integrated Kouzarides, 1996; Ogryzko et al., 1996; Yang et al.,
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were made by insertion of 9E10 or HA epitope oligonucleotides at1996), while both yeast and mammalian deacetylases
the c-fos exon 4 NcoI site in pF711 or p3D.AFos (see Hill et al.,are found in transcriptional corepressor complexes (for
1995). pSRE-lacZ/neo contains three copies of the c-fosA SRE,references, see Pazin and Kadonaga, 1997). Moreover,
linked to the RSV basal promoter and bacterial lacZ coding se-
both p53 and the basal factor TFIIE are substrates for quences (J. Meinkoth and A. S. A., unpublished data). Expression
the CBP/p300 coactivators (Gu and Roeder, 1997; Imhof plasmids were as follows: MKK3E (Raingeaud et al., 1996), Raf-
et al., 1997). These coactivators have been implicated in CAAX (Leevers et al., 1994), MEKEE (Cowley et al., 1994), SEK-AL
(Yan et al., 1994), v-src, RasR12, MEKK1 (Price et al., 1996), Rho-the functions of both the SRE and other c-fos promoter
family proteins, and C3 transferase (Hill et al., 1995), and GST fusionselements (Arias et al., 1994; Janknecht and Nordheim,
containing C3, Cdc42, and RhoA sequences were derived from the1996a, 1996b). It is not yet clear whether the activity of
corresponding expression plasmids (Hill et al., 1995). GST-PAK.NCBP or p300 is regulated by signal transduction path-
and GST-PKN.N contain residues 1±252 from PAK (Manser et al.,
ways, but their potential involvement in the phenomena 1994) and 1±511 from PKN, respectively (Palmer et al., 1994); pGEX.
presented here warrants further investigation. JNK.KA (p54SAPKb K55A) was as described (Yan et al., 1994).
We used chromatin immunoprecipitation experiments
to confirm that H4 hyperacetylation is induced at our Fusion Proteins
chromosomal SRF-controlled reporter genes in response Overnight cultures were diluted 1:10 to 50 ml, grown for 3 hr, lysed
by sonication in 5 ml 25 mM Tris (pH 7.2), 100 mM NaCl, 5 mMto extracellular signals. We have also observed hypera-
MgCl2 with protease inhibitors, adsorbed to glutathione-Sepharosecetylated H4 in c-fos gene chromatin under such condi-
4B (0.5 ml), and washed extensively. Proteins were released bytions (O. G., unpublished data). A previous study, in
overnight incubation at 48C with thrombin (5U; Sigma), which waswhich organomercurial agarose chromatography was
removed by adsorption to p-aminobenzamidine-Sepharose 6B (0.5
used to purify hyperacetylated Balb/C 3T3 nucleosomes ml; Sigma), and protein concentration determined by dye-binding
effectively (Allegra et al., 1987), also strongly suggested assay (Biorad).
that c-fos chromatin becomes hyperacetylated when
the gene is activated (Chen and Allfrey, 1987; Chen et Reporter Cell Lines and Cell Culture
al., 1990). In contrast, a more recent study of HL60 cells Reporter cell lines were generated following transfection of NIH3T3
reported no increase in acetylation of the gene following cells with either SRE-FosHA and pSV2neo or SRE-lacZ/neo by cal-
cium phosphate precipitation. Thirty G418-resistant colonies wereTPA treatment (O'Neill and Turner, 1995). This discrep-
grown up from each transformation. Two lines in which more thanancy may reflect either cell-type differences, high basal
95% of the cells responded to serum stimulation, SRE-FosHA andlevels of acetylase activity in these cells, or the antibod-
SRE-lacZ, were selected for analysis. Cells were passaged in DME/ies used.
10% FCS/0.3 mg/ml G418. Unless otherwise stated, cells were
Extracellular signals such growth factors and stress transferred to DME/0.5% serum for 36 hr before injection and/or
stimuli also induce phosphorylation of chromatin com- stimulation with FCS, 10% (v/v); LPA, 10 mM; TPA, 25 ng/ml; UV,
ponents including histone H3 and HMG14, but the rela- 50 J/m2; anisomycin, 50 ng/ml; SB203580, 10 mM; PD98059, 50 mM;
sodium butyrate, 10 mM; trichostatin A, 10 nM.tion between this and immediate-early gene expression
is unclear (Mahadevan et al., 1991; Edwards and Maha-
Microinjection and Reporter Gene Assaysdevan, 1992; Barratt et al., 1994b). Staining with an anti-
Cells were grown on glass coverslips and injected using a Zeissbody that recognizes phosphorylated H3 indicates that
5171 semiautomated machine using pulled glass capillaries (Albertstreatment with the deacetylase inhibitors does not in-
et al., 1993). For each treatment, 50±100 cells per experiment wereduce H3 phosphorylation (A. S. A., unpublished data).
injected. Reporter DNAs were injected at 10 mg/ml, and expression
These data suggest that H3 phosphorylation is not plasmid DNAs at 50 mg/ml unless otherwise stated. Assuming micro-
necessarily a prerequisite for activation by SRF, but injection of 10%±50% of the nuclear volume of z0.5 fl, we estimate
it remains possible that under certain conditions phos- that 10 mg/ml corresponds to 200±1000 copies per nucleus. Proteins
were injected at the following concentrations in the needle:phorylation of chromatin components can functionally
RhoA.V14, 1.0 mg/ml; Cdc42.V12, 0.5 mg/ml (equal GTP bindingsubstitute for H4 hyperacetylation, or that both hyper-
activity to RhoA.V14), JNK.KA, 3.0 mg/ml; PAK.N, 3.0 mg/ml; PKN.N,acetylation and phosphorylation of c-fos chromatin
3.0 mg/ml; C3 transferase, 50 mg/ml; rabbit or guinea pig markercombine to promote efficient transcription in response
immunoglobulins 5 mg/ml. Reporter gene expression analysis by
to growth factor stimuli. indirect immunofluorescence was with polyclonal pan-Fos, 9E10
In this work, we exploited the fact that in isolation the monoclonal, and for HA, either 12CA5 monoclonal (ICRF) or Y11
SRF-controlled reportergene is a target for only a subset polyclonal (Santa Cruz). In situ b-galactosidase assays were per-
of the signals that can activate the complex chromo- formed as described previously (Alberts et al., 1994).
somal c-fos promoter (see Hill et al., 1995; Price et al.,
1996). For example, activation of the SAPK/JNK path- Immunofluorescence
Staining was essentially as described previously (Alberts et al.,way is sufficient for c-fos activation, presumably be-
1994). Cells were washed and fixed in 4% (v/v) formaldehyde in PBScause it activates other transcription factors such as
for 10 min at room temperature. Following extraction in 0.3% Tritonthe TCFs and CRE binding proteins (for references, see
X-100, cells were incubated with primary antisera in 0.5% NP-40,Price et al., 1996), but can only activate the SRF-con-
1% fish gelatin, 5% whole donkey serum (Sigma) in PBS. Primary
trolled reporter in collaboration with activated RhoA. antibodies were used as follows: R47 anti-acetyllysine (Hebbes et
Our observations therefore establish an additional level al., 1989), 1:300; anti-acetylated H4 (Lin et al., 1989; Meistrich et al.,
at which extracellular signals might act in a combinato- 1992; Perry et al., 1993), 1:8000; 12CA5, 15 mg/ml; Y11, 1:100; 9E10,
rial manner to control gene expression. 10 mg/ml; Fos, 1:100. Secondary antibodies, all donkey, were either
anti-rabbit/Texas red, anti-mouse/FITC, or anti-mouse/lissamine-
rhodamine; marker Ig was detected with anti-guinea pig/AMCA orExperimental Procedures
FITC (Jackson/Stratech, UK) diluted 1:200 in 0.1% Tween 20 in PBS.
Images were either recorded using a Zeiss Axiophot fluorescencePlasmids
microscope (X20 or X40; 1.4 NA) with Kodak TMAX film (ASA 400)DNA was manipulated by standard techniques; full plasmid details
are available on request. Fos-9E10, SRE-FosHA, and SRE-Fos9E10 or captured with similar objectives using a Nikon Microphot-FX
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microscope and a model C5310±11 CCD-camera (Hamamatsu Pho- Archer, T.K., Lefebvre, P., Wolford, R.G., and Hager, G.L. (1992).
Transcription factor loading on the MMTV promoter: a bimodaltonics, UK). Captured images were processed in PICT format using
Adobe Photoshop. mechanism for promoter activation. Science 255, 1573±1576. (Erra-
tum, 256[5054]:161).
Histone Preparation and Immunoblotting Arias, J., Alberts, A.S., Brindle, P., Claret, F.X., Smeal, T., Karin, M.,
Histone extracts were prepared by acid extraction with 0.25 M HCl, Feramisco, J., and Montminy, M. (1994). Activation of cAMP and
extracted into phenol, and recovered by acetone precipitation as mitogen responsivegenes relieson a common nuclear factor. Nature
described (Nicolas, 1990). Proteins were dissolved in 8 M urea, 5% 370, 226±229.
acetic acid, 5% b-mercaptoethanol, fractionated on 15% acryl- Bannister, A.J., and Kouzarides, T. (1996). The CBP co-activator is
amide/5% acetic acid/4 M urea gels, and transferred to Immobilon-P a histone acetyltransferase. Nature 384, 641±643.
in 0.1% acetic acid/10% methanol overnight at 40 V. Membranes
Barratt, M.J., Hazzalin, C.A., Cano, E., and Mahadevan, L.C. (1994a).were incubated with R47 (1:1000), anti-acetylated H4 (1:1000), or
Mitogen-stimulated phosphorylation of histone H3 is targeted to aanti-acetylated H3 (1:7000) in PBS, 5% nonfat-dried milk, 0.1%
small hyperacetylation-sensitive fraction. Proc. Natl. Acad. Sci. USA
Tween 20 at room temperature, followed by horseradish peroxidase-
91, 4781±4785.
conjugated goat anti-rabbit IgG (DAKO), and histones detected by
Barratt, M.J., Hazzalin, C.A., Zhelev, N., and Mahadevan, L.C.chemiluminescence (ECL; Amersham, UK).
(1994b). A mitogen- and anisomycin-stimulated kinase phosphory-
lates HMG-14 in its basic amino-terminal domain in vivo and onChromatin Immunoprecipitation
isolated mononucleosomes. EMBO J. 13, 4524±4535.The method of Braunstein and coworkers (Braunstein et al., 1993)
Braunstein, M., Rose, A.B., Holmes, S.G., Allis, C.D., and Broach,was adapted as follows. Cells from a 9 cm dish (5 3 105 cells) were
J.R. (1993). Transcriptional silencing in yeast is associated withcross-linked by addition of 1% HCHO to the medium for 10 min.
reduced nucleosome acetylation. Genes Dev. 7, 592±604.Crude nuclei prepared by hypotonic lysis were resuspended in 100
Bresnick, E.H., John, S., Berard, D.S., LeFebvre, P., and Hager, G.L.ml SDS lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl (pH 8.1),
(1990). Glucocorticoid receptor-dependent disruption of a specificsonicated under conditions that reduced DNA length to between 200
nucleosome on the mouse mammary tumor virus promoter is pre-and 1000 base pairs, and debris removed by centrifugation. The
vented by sodium butyrate. Proc. Natl. Acad. Sci. USA 87, 3977±chromatin solution was diluted 10-fold in IP buffer (Braunstein et
3981.al., 1993) and precleared for 459 at 48C on protein A beads pread-
sorbed with sonicated single-stranded DNA. The chromatin solution Cereghini, S., and Yaniv, M. (1984). Assembly of transfected DNA
was then incubated with anti-AcH4 antibody (0.2 ml; Lin et al., 1989) into chromatin: structural changes in the origin-promoter-enhancer
for 2 hr at 48C, and immune complexes collected with protein A region upon replication. EMBO J. 3, 1243±1253.
beads preadsorbed with sonicated single-stranded DNA. Following Chen, T.A., and Allfrey, V.G. (1987). Rapid and reversible changes
washes and elution (Braunstein et al., 1993), cross-links were re- in nucleosome structure accompany the activation, repression, and
versed by heating at 658C for 4±5 hr; DNA was recovered by phenol superinduction of murine fibroblast protooncogenes c-fos and
extraction and ethanol precipitation. Specific sequences in the im- c-myc. Proc. Natl. Acad. Sci. USA 84, 5252±5256.
munoprecipitates were detected by PCR under conditions in which
Chen, T.A., Sterner, R., Cozzolino, A., and Allfrey, V.G. (1990). Re-
product yield was dependent on input DNA dose, using primers versible and irreversible changes in nucleosome structure along the
specific for the SRE-lacZ or SRE-FosHA reporter genes. The basal c-fos and c-myc oncogenes following inhibition of transcription. J.
level of acetylated H4 necessitated immunoprecipitation using sub- Mol. Biol. 212, 481±493.
saturating levels of antibody.
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